Marker Therapeutics, Inc. (MRKR)
2.12
+0.31
(+17.13%)
USD |
NASDAQ |
Jan 20, 16:00
2.08
-0.04
(-1.89%)
After-Hours: 05:20
Marker Therapeutics Total Return Level: 2.12 for Jan. 20, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Viridian Therapeutics, Inc. | 32.64 |
| ADMA Biologics, Inc. | 17.59 |
| Kiniksa Pharmaceuticals International Plc | 41.03 |
| Neurocrine Biosciences, Inc. | 134.54 |
| AIM ImmunoTech, Inc. | 1.18 |